Fabricant Ends Eventful Service In FDA Supplement Regulation To Head NPA
This article was originally published in The Tan Sheet
Daniel Fabricant will be the CEO of NPA, and leave his post as director of FDA’s Division of Dietary Supplement Programs, the association announced April 8.
You may also be interested in...
FDA Dietary Supplement Programs Research, Strategy Official Moves To NPA
Sibyl Swift is responsible for developing and implementing NPA's educational, regulatory and compliance programs such as SSCI and the NPA Natural Standard. She also will assist members with claim reviews, substantiation and NDI notification policy.
NPA Internal Review Sparked Suit Against Board Members, Ongoing Changes
A review launched after NPA's former CFO filed a wrongful termination complaint in November refuted the allegations, but has "also shown that there was some governance that needed to change," says Executive Director and CEO Daniel Fabricant.
Dr. Oz Grilling In Senate Tops 2014 Dietary Supplement News
Articles on the potential that debate around the benefits of fish oils will damage consumer regard for omega-3 supplements, FDA’s guidance on distinguishing between liquid supplements and conventional beverages and Daniel Fabricant’s exit from FDA’s supplement regulation office also were highly read in 2014.